|
 |
|
|||||||
|
|||||||||
Diabetes 51:1889-1895, 2002
© 2002 by the American Diabetes Association, Inc.
High Alanine Aminotransferase Is Associated With Decreased Hepatic Insulin Sensitivity and Predicts the Development of Type 2 Diabetes
From the Clinical Diabetes and Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona
It has been proposed that liver dysfunction may contribute to the development of type 2 diabetes. The aim of the present study was to examine whether elevated hepatic enzymes (alanine aminotransferase [ALT], aspartate aminotransferase [AST], or 
-glutamyltranspeptidase [GGT]) are associated with prospective changes in liver or whole-body insulin sensitivity and/or insulin secretion and whether these elevated enzymes predict the development of type 2 diabetes in Pima Indians. We measured ALT, AST, and GGT in 451 nondiabetic (75-g oral glucose tolerance test) Pima Indians (aged 30 ± 6 years, body fat 33 ± 8%, ALT 45 ± 29 units/l, AST 34 ± 18 units/l, and GGT 56 ± 40 units/l [mean ± SD]) who were characterized for body composition (hydrodensitometry or dual-energy X-ray absorptiometry), whole-body insulin sensitivity (M), and hepatic insulin sensitivity (hepatic glucose output [HGO] during the low-dose insulin infusion of a hyperinsulinemic clamp) and acute insulin response (AIR) (25-g intravenous glucose challenge). Sixty-three subjects developed diabetes over an average follow-up of 6.9 ± 4.9 years. In 224 subjects, who remained nondiabetic, follow-up measurements of M and AIR were available. At baseline, ALT, AST, and GGT were related to percent body fat (r = 0.16, 0.17, and 0.11, respectively), M (r = -0.32, - 0.28, and -0.24), and HGO (r = 0.27, 0.12, and 0.14; all P < 0.01). In a proportional hazard analysis with adjustment for age, sex, body fat, M, and AIR, higher ALT [relative hazard 90th vs. 10th centiles (95% CI): 1.9 (1.1–3.3), P = 0.02], but not AST or GGT, predicted diabetes. Elevated ALT at baseline was associated prospectively with an increase in HGO (r = 0.21, P = 0.001) but not with changes in M or AIR (both P = 0.1). Higher ALT concentrations were cross-sectionally associated with obesity and whole-body and hepatic insulin resistance and prospectively associated with a decline in hepatic insulin sensitivity and the development of type 2 diabetes. Our findings indicate that high ALT is a marker of risk for type 2 diabetes and suggest a potential role of the liver in the pathogenesis of type 2 diabetes.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Shibata, Y. Kihara, M. Taguchi, M. Tashiro, and M. Otsuki Nonalcoholic Fatty Liver Disease Is a Risk Factor for Type 2 Diabetes in Middle-Aged Japanese Men Diabetes Care, November 1, 2007; 30(11): 2940 - 2944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. H. Cho, H. C. Jang, S. H. Choi, H. R. Kim, H. K. Lee, J. C.N. Chan, and S. Lim Abnormal Liver Function Test Predicts Type 2 Diabetes: A community-based prospective study Diabetes Care, October 1, 2007; 30(10): 2566 - 2568. [Full Text] [PDF]
|
|
|
|
|
|
T. M. Wallace, K. M. Utzschneider, J. Tong, D. B. Carr, S. Zraika, D. D. Bankson, R. H. Knopp, and S. E. Kahn Relationship of Liver Enzymes to Insulin Sensitivity and Intra-Abdominal Fat Diabetes Care, October 1, 2007; 30(10): 2673 - 2678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Andre, B. Balkau, S. Vol, M. A. Charles, E. Eschwege, and on behalf of the DESIR Study Group {gamma}-Glutamyltransferase Activity and Development of the Metabolic Syndrome (International Diabetes Federation Definition) in Middle-Aged Men and Women: Data From the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort Diabetes Care, September 1, 2007; 30(9): 2355 - 2361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kolak, J. Westerbacka, V. R. Velagapudi, D. Wagsater, L. Yetukuri, J. Makkonen, A. Rissanen, A.-M. Hakkinen, M. Lindell, R. Bergholm, et al. Adipose Tissue Inflammation and Increased Ceramide Content Characterize Subjects With High Liver Fat Content Independent of Obesity Diabetes, August 1, 2007; 56(8): 1960 - 1968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Koska, E. Ortega, C. Bogardus, J. Krakoff, and J. C. Bunt The effect of insulin on net lipid oxidation predicts worsening of insulin resistance and development of type 2 diabetes mellitus Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E264 - E269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J.G. Hanley, L. E. Wagenknecht, A. Festa, R. B. D'Agostino Jr., and S. M. Haffner Alanine Aminotransferase and Directly Measured Insulin Sensitivity in a Multiethnic Cohort: The Insulin Resistance Atherosclerosis Study Diabetes Care, July 1, 2007; 30(7): 1819 - 1827. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sattar, A. McConnachie, I. Ford, A. Gaw, S. J. Cleland, N. G. Forouhi, P. McFarlane, J. Shepherd, S. Cobbe, and C. Packard Serial Metabolic Measurements and Conversion to Type 2 Diabetes in the West of Scotland Coronary Prevention Study: Specific Elevations in Alanine Aminotransferase and Triglycerides Suggest Hepatic Fat Accumulation as a Potential Contributing Factor Diabetes, April 1, 2007; 56(4): 984 - 991. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Chang, S. Ryu, E. Sung, and Y. Jang Higher Concentrations of Alanine Aminotransferase within the Reference Interval Predict Nonalcoholic Fatty Liver Disease Clin. Chem., April 1, 2007; 53(4): 686 - 692. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Perseghin, G. Lattuada, F. De Cobelli, F. Ragogna, G. Ntali, A. Esposito, E. Belloni, T. Canu, I. Terruzzi, P. Scifo, et al. Habitual Physical Activity Is Associated With Intrahepatic Fat Content in Humans Diabetes Care, March 1, 2007; 30(3): 683 - 688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Whitfield Serum {gamma}-Glutamyltransferase and Risk of Disease Clin. Chem., January 1, 2007; 53(1): 1 - 2. [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Utzschneider and S. E. Kahn The Role of Insulin Resistance in Nonalcoholic Fatty Liver Disease J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4753 - 4761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. S. Burgert, S. E. Taksali, J. Dziura, T. R. Goodman, C. W. Yeckel, X. Papademetris, R. T. Constable, R. Weiss, W. V. Tamborlane, M. Savoye, et al. Alanine Aminotransferase Levels and Fatty Liver in Childhood Obesity: Associations with Insulin Resistance, Adiponectin, and Visceral Fat J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4287 - 4294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Ortega, J. Koska, A. D. Salbe, P. A. Tataranni, and J. C. Bunt Serum {gamma}-Glutamyl Transpeptidase Is a Determinant of Insulin Resistance Independently of Adiposity in Pima Indian Children J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1419 - 1422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Wannamethee, A. G. Shaper, L. Lennon, and P. H. Whincup Hepatic Enzymes, the Metabolic Syndrome, and the Risk of Type 2 Diabetes in Older Men Diabetes Care, December 1, 2005; 28(12): 2913 - 2918. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Schindhelm, J. M. Dekker, G. Nijpels, R. J. Heine, and M. Diamant No Independent Association of Alanine Aminotransferase With Risk of Future Type 2 Diabetes in the Hoorn Study Diabetes Care, November 1, 2005; 28(11): 2812 - 2812. [Full Text] [PDF]
|
|
|
|
|
|
A. J.G. Hanley, K. Williams, A. Festa, L. E. Wagenknecht, R. B. D'Agostino Jr, and S. M. Haffner Liver Markers and Development of the Metabolic Syndrome: The Insulin Resistance Atherosclerosis Study Diabetes, November 1, 2005; 54(11): 3140 - 3147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Bloomgarden Inflammation, Atherosclerosis, and Aspects of Insulin Action Diabetes Care, September 1, 2005; 28(9): 2312 - 2319. [Full Text] [PDF]
|
|
|
|
 |
|
 E. H. Harris Elevated Liver Function Tests in Type 2 Diabetes Clin. Diabetes, July 1, 2005; 23(3): 115 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Lawlor, N. Sattar, G. D. Smith, and S. Ebrahim The Associations of Physical Activity and Adiposity with Alanine Aminotransferase and Gamma-Glutamyltransferase Am. J. Epidemiol., June 1, 2005; 161(11): 1081 - 1088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. H. Pietilainen, A. Rissanen, J. Kaprio, S. Makimattila, A.-M. Hakkinen, J. Westerbacka, J. Sutinen, S. Vehkavaara, and H. Yki-Jarvinen Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance in young adult monozygotic twins Am J Physiol Endocrinol Metab, April 1, 2005; 288(4): E768 - E774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S G Kim, H Y Kim, J A Seo, K W Lee, J H Oh, N H Kim, K M Choi, S H Baik, and D S Choi Relationship between serum adiponectin concentration, pulse wave velocity and nonalcoholic fatty liver disease Eur. J. Endocrinol., February 1, 2005; 152(2): 225 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Lee, K. Silventoinen, D. R. Jacobs Jr., P. Jousilahti, and J. Tuomileto {gamma}-Glutamyltransferase, Obesity, and the Risk of Type 2 Diabetes: Observational Cohort Study among 20,158 Middle-Aged Men and Women J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5410 - 5414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sattar, O. Scherbakova, I. Ford, D. St. J. O'Reilly, A. Stanley, E. Forrest, P. W. MacFarlane, C. J. Packard, S. M. Cobbe, and J. Shepherd Elevated Alanine Aminotransferase Predicts New-Onset Type 2 Diabetes Independently of Classical Risk Factors, Metabolic Syndrome, and C-Reactive Protein in the West of Scotland Coronary Prevention Study Diabetes, November 1, 2004; 53(11): 2855 - 2860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J.G. Hanley, K. Williams, A. Festa, L. E. Wagenknecht, R. B. D'Agostino Jr., J. Kempf, B. Zinman, and S. M. Haffner Elevations in Markers of Liver Injury and Risk of Type 2 Diabetes: The Insulin Resistance Atherosclerosis Study Diabetes, October 1, 2004; 53(10): 2623 - 2632. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yki-Jarvinen Thiazolidinediones N. Engl. J. Med., September 9, 2004; 351(11): 1106 - 1118. [Full Text] [PDF]
|
|
|
|
|
|
C. Wilson Hepatitis C Infection and Type 2 Diabetes in American-Indian Women Diabetes Care, September 1, 2004; 27(9): 2116 - 2119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Manning, W. H.F. Sutherland, R. J. Walker, S. M. Williams, S. A. de Jong, A. R. Ryalls, and E. A. Berry Effect of High-Dose Vitamin E on Insulin Resistance and Associated Parameters in Overweight Subjects Diabetes Care, September 1, 2004; 27(9): 2166 - 2171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Fernandez-Real, A. Lopez-Bermejo, M. Broch, J. Vendrell, C. Richart, and W. Ricart Circulating Soluble CD14 Monocyte Receptor Is Associated with Increased Alanine Aminotransferase Clin. Chem., August 1, 2004; 50(8): 1456 - 1458. [Full Text] [PDF]
|
|
|
|
|
|
U. Hanusch-Enserer, E. Cauza, G. Brabant, A. Dunky, H. Rosen, G. Pacini, H. Tuchler, R. Prager, and M. Roden Plasma Ghrelin in Obesity before and after Weight Loss after Laparoscopical Adjustable Gastric Banding J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3352 - 3358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Donati, B Stagni, F Piscaglia, N Venturoli, A M Morselli-Labate, L Rasciti, and L Bolondi Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance Gut, July 1, 2004; 53(7): 1020 - 1023. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Pearson, M. K. Badman, C. R. Lockwood, P. M. Clark, S. Ellard, C. Bingham, and A. T. Hattersley Contrasting Diabetes Phenotypes Associated With Hepatocyte Nuclear Factor-1{alpha} and -1{beta} Mutations Diabetes Care, May 1, 2004; 27(5): 1102 - 1107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. L. Muller, C. Bogardus, B. A. Beamer, A. R. Shuldiner, and L. J. Baier A Functional Variant in the Peroxisome Proliferator-Activated Receptor {gamma}2 Promoter Is Associated With Predictors of Obesity and Type 2 Diabetes in Pima Indians Diabetes, July 1, 2003; 52(7): 1864 - 1871. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cianfarani, A. Maiorana, C. Geremia, G. Scire, G. L. Spadoni, and D. Germani Blood Glucose Concentrations are Reduced in Children Born Small for Gestational Age (SGA), and Thyroid-Stimulating Hormone Levels are Increased in SGA with Blunted Postnatal Catch-up Growth J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2699 - 2705. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |